BeStock  
Markets › Compare › NBIX vs TEVA

NBIX vs TEVA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NBIX · Neurocrine Biosciences$142.43 ▲ 0.42%
TEVA · Teva Pharmaceutical Industries$39.24 ▼ 0.91%

Head to head

MetricNBIXTEVA
Price$142.43$39.24
Change today▲ 0.42%▼ 0.91%
Market cap$14.48B$45.77B
Return, 3 months––
Return, year to date––
Return, 1 year––
P/E (TTM)20.865.4
P/B3.95.9
P/E percentile vs own 5y–100th
Dividend yield––
Revenue growth (YoY, latest qtr)–-0.8%
Net profit growth (YoY)–-303.2%
Gross margin–52.5%
Operating margin–18.7%
Net margin–4.1%
Return on equity–9.7%
Analyst target vs. price+47.4%+14.7%
Analyst buy share88%100%
RSI (14)––
30-day volatility––
Max drawdown, 1 year––
Trend read––
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TEVA is the largest of the group by market value.
  • NBIX carries the lowest trailing P/E.

Go deeper

Scroll to Top